Relmada Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Relmada Therapeutics stock have an average target of 10.25, with a low estimate of 8.00 and a high estimate of 14. The average target predicts an increase of 132.95% from the current stock price of 4.40.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$10.25	$10	$14
Change	+81.82%	+132.95%	+127.27%	+218.18%

Analyst Ratings

The average analyst rating for Relmada Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	0	1	1	1	2
Buy	0	1	1	2	2	2
Hold	2	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	1	0	0	0	0	0
Total	4	2	2	3	3	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christopher Liu LUCID CAPITAL MARKETS	LUCID CAPITAL MARKETS	Strong Buy Initiates $14	Strong Buy	Initiates	$14	+218.18%	Mar 2, 2026
Andrew Berens Leerink Partners	Leerink Partners	Hold → Buy Upgrades $8	Hold → Buy	Upgrades	$8	+81.82%	Jan 23, 2026
Farzin Haque Jefferies	Jefferies	Strong Buy Initiates $9	Strong Buy	Initiates	$9	+104.55%	Dec 22, 2025
Uy Ear Mizuho	Mizuho	Hold → Buy Upgrades $1 → $10	Hold → Buy	Upgrades	$1 → $10	+127.27%	Nov 19, 2025
Uy Ear Mizuho	Mizuho	Buy → Hold Downgrades $23 → $1	Buy → Hold	Downgrades	$23 → $1	-77.27%	Dec 5, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.19

from -2.65

EPS Next Year

-0.66

from -1.19

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.81	-7.16	-5.30	-3.28	-2.65	-1.19	-0.66
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-1.17	-0.61
Avg	-1.19	-0.66
Low	-1.21	-0.71

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.